Showing results (51-60 of 77) with videos related to
Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry|July 2, 2005
Synthetic studies on novel Syk inhibitors. Part 1: Synthesis and structure-activity relationships of pyrimidine-5-carboxamide derivativesHiroyuki Hisamichi, Ryo Naito, Akira Toyoshima, et al.Bioorganic & Medicinal Chemistry|July 14, 2006
Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110alpha inhibitorsMasahiko Hayakawa, Hiroyuki Kaizawa, Hiroyuki Moritomo, et al.Bioorganic & Medicinal Chemistry Letters|October 11, 2012
Pyrrolidinyl phenylurea derivatives as novel CCR3 antagonistsAiko Nitta, Yosuke Iura, Hideki Inoue, et al.Bioorganic & Medicinal Chemistry|June 7, 2008
Identification of 4-benzylamino-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5-carboxamide derivatives as potent and orally bioavailable STAT6 inhibitorsShinya Nagashima, Hiroshi Nagata, Masahiro Iwata, et al.Bioorganic & Medicinal Chemistry|August 13, 2008
Potent CCR4 antagonists: synthesis, evaluation, and docking study of 2,4-diaminoquinazolinesKazuhiro Yokoyama, Noriko Ishikawa, Susumu Igarashi, et al.Bioorganic & Medicinal Chemistry Letters|July 4, 2012
Discovery and structure-activity relationships of urea derivatives as potent and novel CCR3 antagonistsAiko Nitta, Yosuke Iura, Hiroki Tomioka, et al.Journal of Medicinal Chemistry|August 22, 2012
Identification, synthesis, and biological evaluation of 6-[(6R)-2-(4-fluorophenyl)-6-(hydroxymethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3(2H)-one (AS1940477), a potent p38 MAP kinase inhibitorToru Asano, Hitoshi Yamazaki, Chiyoshi Kasahara, et al.Bioorganic & Medicinal Chemistry|March 12, 2003
New thiazole derivatives as potent and selective 5-hydroxytriptamine 3 (5-HT3) receptor agonists for the treatment of constipationNaoki Imanishi, Kiyoshi Iwaoka, Hiroyuki Koshio, et al.Bioorganic & Medicinal Chemistry|August 30, 2008
Design and synthesis of 6-fluoro-2-naphthyl derivatives as novel CCR3 antagonists with reduced CYP2D6 inhibitionIppei Sato, Koichiro Morihira, Hiroshi Inami, et al.Bioorganic & Medicinal Chemistry Letters|October 4, 2011
Identification of 4-quinolone derivatives as inhibitors of reactive oxygen species production from human umbilical vein endothelial cellsKenichi Onda, Fumie Narazaki, Naoki Ishibashi, et al.Pageof 8